Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Gemcitabine in Bladder Cancer Post-Cystectomy
NCT00146276Phase 3Unknown
- Sponsor
- Society of Urologic Oncology
- Start
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in transitional cell carcinoma of the bladder (TCC), sponsored by Society of Urologic Oncology. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
transitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on NCT00146276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146276.